SS-31
A mitochondria-targeted tetrapeptide that binds cardiolipin on the inner mitochondrial membrane, preserving cristae structure and improving ATP production. Studied in aging, heart failure, and metabolic disease.
Half-life
~2–4 hours
Typical vial
10 mg / 50 mg
Mechanism
Selective cardiolipin binding stabilizes the electron transport chain, reduces ROS leakage, and restores mitochondrial bioenergetics.
Research Applications
- Heart failure models
- Primary mitochondrial disease
- Sarcopenia / aging muscle
- Ischemia–reperfusion injury
Handling & Storage
Store lyophilized refrigerated. Reconstitute with water and refrigerate.
Compliance notice: All materials are sold strictly for in vitro laboratory research. Not a drug, supplement, food, or cosmetic. Not for human or veterinary use, diagnosis, treatment, or consumption. No medical claims are made or implied. Buyers must be qualified researchers ≥21 years of age and agree to handle materials in compliance with all applicable local, state, and federal laws.